Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Review of Clinical Pharmacology|April 1, 2016
Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implicationsDiana L Hanna, Heinz-Josef Lenz
Therapeutic Advances in Medical Oncology|May 4, 2026
Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyondAni Misirian, Jonathan Pai, Diana L Hanna
Critical Reviews in Oncology/Hematology|March 26, 2013
Biomolecular markers of cancer-associated thromboembolismDiana L Hanna, Richard H White, Ted Wun
Cancer Treatment Reviews|May 24, 2021
Cabozantinib: An evolving therapy for hepatocellular carcinomaAnthony B El-Khoueiry, Diana L Hanna, Josep Llovet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2016
Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer TreatmentYuji Miyamoto, Diana L Hanna, Wu Zhang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 24, 2017
Colorectal cancer: epigenetic alterations and their clinical implicationsAlberto Puccini, Martin D Berger, Madiha Naseem, et al.
Cancer Science|December 11, 2019
Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenibSatoshi Matsusaka, Diana L Hanna, Yan Ning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2016
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based ChemotherapySatoshi Matsusaka, Diana L Hanna, Shu Cao, et al.
Molecular Cancer Therapeutics|October 31, 2013
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapyYan Ning, Armin Gerger, Wu Zhang, et al.
Pageof 3